Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle

Molecular Human Reproduction

Volumn 7, Issue 1, 2001, Pages 65-72

  Moller B ^a   Rasmussen, C ^a   Lindblom, B ^a   Olovsson, M ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Angiogenesis; EGF; Endometrium; FGF 2; VEGF

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; EPITOPE; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; STEROID; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL FUNCTION; CAPILLARY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; FEMALE FERTILITY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; ENDOMETRIUM; ENDOTHELIAL GROWTH FACTORS; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOKINES; MENSTRUAL CYCLE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035143682     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/7.1.65     Document Type: Article

References (64)

1. Angiogenesis in the endometrium
2. Menstrual cycle specific expression of epidermal growth factor receptors in human fallopian tube epithelium
3. Co-localization of vascular endothelial growth factor and its Flt-1 receptor in human placenta
4. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding
5. Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects
6. Smoking reduces the biological capacity of conception. Results from a European multicenter study. The European study group on infertility and subfecundity
7. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor
8. Identification and localisation of alternatively spliced mRNAs for Vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell line
9. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
10. Effects of cigarette smoking, caffeine consumption, and alcohol intake on fecundability
11. Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction
12. Tumor angiogenesis
13. Heparin-binding growth factor 1 stimulates tyrosine phosphorylisation in NIH 3T3 cells
14. Growth factors and growth modulators in human Uterine endometrium: Their potential relevance to reproductive medicine
15. Endometrial endothelial cell proliferation during the menstrual cycle
16. Estrogen regulates the synthesis of epidermal growth factor in mouse uterine epithelial cells
17. Regulation of VEGF in the reproductive tract by sex-steroid hormones
18. Changes in epidermal growth factor receptor and the levels of its ligands during menstrual cycle in human endometrium
19. Endometrial endothelial cells express estrogen and progesterone receptors to angiogenic growth factors
20. Epidermal growth factor-like immunoreactivity in human endometrium
21. Vascular endothelial growth factor and its receptors
22. Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation
23. A novel function of VEGF receptor-2 (KDR): Rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells
24. Expression of mRNA for vascular endothelial growth factor transmembranous receptors Flt1 and KDR, and the soluble receptor silt in cycling human endometrium
25. Immunolocalisation of vascular endothelial growth factor in human endometrium
26. The regulatory effects of cytokines or lymphatic angiogenesis
27. In vivo estrogen regulation of epidermal growth factor receptor in human endometrium
28. Expression of vascular endothelial growth factor receptors in human endometrium: Modulation during the menstrual cycle
29. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking
30. Angiogenesis in normal, hyperplastic, and neoplastic endometrium
31. Menstrual stage-specific expression of epidermal growth factor and transforming growth factor-α in human oviduct epithelium and their role in early embryogenesis
32. Regulation of epidermal growth factor receptor by estrogen
33. Immunohistological localisation of vascular endothelial growth factor in human endometrium
34. Dating the endometrial biopsy
35. Recombinant human epidermal growth factor and corneal neovascularization
36. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium
37. Expression of protein tyrosine kinases in islet cells: Possible role of the Flk-1 receptor for beta-cell maturation from duct cells
38. Angiogenesis-regulating cytokines: Activities and interactions
39. mRNA expression of ligands of the epidermal growth factor receptor in the uterus
40. Mechanisms of angiogenesis
41. Endothelial cell migratory signal produced by human endometrium during the menstrual cycle
42. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel
43. Endometrial vascular growth in normal and dysfunctional states
44. Smoking and cycle control among oral contraceptive users
45. Estro-progestinic replacement therapy modulates the levels of basic fibroblast growth factor (FGF-2) in postmenopausal endometrium
46. Fibroblast growth factor receptor-1 is a critical component for endometrial remodeling: Localization and expression of basic fibroblast growth factor and FGF-R1 in human endometrium during the menstrual cycle and decreased FGF-R1 expression in menorrhagia
47. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia
48. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiosgenesis during the menstrual cycle and in the pathogenesis of endometriosis
49. Distinct patterns of expression of keratinocyte growth factor and its receptor in endometrial carcinoma
50. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma
51. Angiogenic growth factor expression in the uterus
52. Angiogenesis
53. Macrophages and angiogenesis
54. Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta
55. Vascular endothelial growth factor expression in cycling human endometrium
56. No cyclicity in serum vascular endothelial growth factor during normal menstrual cycle but significant luteal phase elevation during an in vitro fertilization program
57. Heparin-binding epidermal growth factor-like growth factor: P91 Activation induction of plasminogen activator/inhibitor, and tubular morphogenesis in human microvascular endothelial cells
58. Anti-estrogenic effect of cigarette smoking
59. Heterogenous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant
60. Immunohistochemical and localization of vascular endothelial growth factor (VEGF) its two specific receptors Flt-1 and KDR, in the porcine placenta and non-pregnant uterus